B, H., G, L., K, Z., & G, Z. (2024). Diversity of extracellular HSP70 in cancer: Advancing from a molecular biomarker to a novel therapeutic target. Frontiers in oncology, 14, 1388999. https://doi.org/10.3389/fonc.2024.1388999
Chicago Style (17th ed.) CitationB, Hu, Liu G, Zhao K, and Zhang G. "Diversity of Extracellular HSP70 in Cancer: Advancing from a Molecular Biomarker to a Novel Therapeutic Target." Frontiers in Oncology 14 (2024): 1388999. https://doi.org/10.3389/fonc.2024.1388999.
MLA (9th ed.) CitationB, Hu, et al. "Diversity of Extracellular HSP70 in Cancer: Advancing from a Molecular Biomarker to a Novel Therapeutic Target." Frontiers in Oncology, vol. 14, 2024, p. 1388999, https://doi.org/10.3389/fonc.2024.1388999.
Warning: These citations may not always be 100% accurate.